Description
The abstract states that exercise remains the primary therapeutic modality and new treatment targets are needed, implying failure of other interventions. The mechanistic basis for why IBM resists most therapeutic approaches while responding to exercise is not explained, limiting rational drug development.
Gap type: open_question Source paper: Inclusion body myositis: an update. (2025, Current opinion in rheumatology, PMID:39469805)